Previous Article | Next Article ![]()
Infection and Immunity, September 1998, p. 4450-4460, Vol. 66, No. 9
Departments of
Microbiology1 and
Pathology,2 College of Physicians
and Surgeons, Columbia University, New York, New York 10032
Received 6 April 1998/Returned for modification 13 May
1998/Accepted 29 May 1998
During infection, the Legionnaires' disease bacterium,
Legionella pneumophila, survives and multiplies within a
specialized phagosome that is near neutral pH and does not fuse with
host lysosomes. In order to understand the molecular basis of this organism's ability to control its intracellular fate, we have isolated
and characterized a group of transposon-generated mutants which were
unable to kill macrophages and were subsequently found to be defective
in intracellular multiplication. These mutations define a set of 20 genes (19 icm [for intracellular multiplication] genes
and dotA [for defect in organelle trafficking]). In this report, we describe a quantitative assay for phagosome-lysosome fusion
(PLF) and its use to measure the levels of PLF in cells that have been
infected with either wild-type L. pneumophila or one of
several mutants defective in different icm genes or
dotA. By using quantitative confocal fluorescence
microscopy, PLF could be scored on a per-bacterium basis by determining
the extent to which fluorescein-labeled L. pneumophila
colocalized with host lysosomes prelabeled with rhodamine-dextran.
Remarkably, mutations in the six genes that were studied resulted in
maximal levels of PLF as quickly as 30 min following infection. These
results indicate that several, and possibly all, of the icm
and dotA gene products act at an early step during
phagosome establishment to determine whether L. pneumophila-containing phagosomes will fuse with lysosomes.
Although not ruled out, subsequent activity of these gene products may
not be necessary for successful intracellular replication.
Legionella pneumophila
(the Legionnaires' disease bacterium) is a gram-negative bacterium
that grows within a wide range of phagocytic host cells, ranging from
freshwater amoebae to mammalian macrophages (M Genetic analysis has provided some information about the bacterial
genes that are required for the ability of L. pneumophila to specifically replicate within human M Two models can be considered for how the icm and
dotA genes may act during these intracellular events. In a
sequential model, subsets of the genes would be expressed temporally so
that L. pneumophila may direct its phagosome to
maintain nearly neutral pH; prevent phagosome-lysosome fusion (PLF);
associate sequentially with smooth vesicles, mitochondria, and
ribosomes; and promote bacterial replication. Alternatively, in a
concerted model, all the genetic information in the bacteria is
expressed prior to infection so that the incoming L. pneumophila can form a specialized phagosome that possesses all
the properties needed for intracellular life. Subsequent events would
then be dictated by the features of the LSP that are established during
its formation or shortly thereafter. These models should be
distinguishable by analysis of the icm and dotA
mutants that fail to replicate within M In this paper we describe measurements of PLF for cells infected with
either wild-type L. pneumophila or strains with
mutations in five different icm genes and the
dotA gene. We find that in contrast to the cells infected
with wild-type L. pneumophila, cells infected with the
mutants exhibited maximal levels of PLF as rapidly as 30 min following
infection. Indeed, the levels of PLF of cells infected with the mutants
were indistinguishable from the levels of PLF observed in cells
infected with paraformaldehyde (Para)-killed bacteria, indicating that
the mutants had no measurable ability to prevent PLF. These results are
consistent with a concerted model of gene expression in which many or
all of the icm and dotA gene products act
together either during phagosome formation or shortly thereafter to
produce an LSP compartment that does not fuse with lysosomes. For
L. pneumophila, it appears that early events in M Reagents.
5,6-Carboxyfluorescein succinimidyl ester (FSE)
(catalog no. C-1311) and tetramethylrhodamine dextran (Rh-dextran)
(70,000 molecular weight [MW], lysine fixable) (catalog no. D-1818)
were purchased from Molecular Probes (Seattle, Wash.). Also purchased were RPMI 1640 medium lacking L-glutamine (RPMI) (JRH
Biosciences, Lenexa, Kans.), L-glutamine (Gln) (Mediatech,
Washington, D.C.), and agarose (IBI, New Haven, Conn.). Normal human
serum (NHS) was obtained from healthy male volunteers and stored in
5-ml aliquots at Bacterial strains.
All bacteria were derived from
L. pneumophila Philadelphia-1 and are described in
Table 1.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Early Events in Phagosome Establishment Are
Required for Intracellular Survival of Legionella
pneumophila

and
![]()
ABSTRACT
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
![]()
INTRODUCTION
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
s). Although the
cytological events that occur during infection of human M
s have been
described in great detail, there is little information about the
molecular basis for the ability of this organism to survive and
replicate within host cells. Infection of human M
s by L. pneumophila appears to occur by a sequential multistep process
(for reviews, see references 25, 31, and
39). Following attachment to complement receptors, the bacteria are engulfed either by a single pseudopod that coils around the bacterium (20) or by conventional phagocytosis
(35). In the former case, the multilayered membrane of the
coiled pseudopod resolves to form a phagosome. During this phagosome
formation, a sorting of plasma membrane proteins occurs so that some
markers are excluded from the phagosomal membrane while others are
included (7, 8). The phagosome containing live wild-type
L. pneumophila does not acidify below pH 6, nor does it
fuse with host lysosomes (19, 21). Instead, this
Legionella-specific phagosome (LSP) goes through a series of
intracellular trafficking events, associating sequentially with smooth
vesicles, mitochondria, and ribosomes (18). After 4 to
6 h postinfection, the LSP becomes ribosome studded and seems to
be surrounded by rough endoplasmic reticulum, as indicated by the
presence of the endoplasmic reticulum luminal marker BiP (18,
42). At approximately 10 h postinfection, L. pneumophila begins to multiply inside the LSP. Eventually, the
host cell is lysed, releasing L. pneumophila which can
then initiate new rounds of infection.
s. Two
regions within the L. pneumophila genome have been
identified which encode a total of 20 genes (19 icm genes
and dotA) that are dispensable for growth on bacteriologic
media but are required for intracellular replication and host cell
killing (2, 4, 29, 34, 37, 38). These genes are likely to
encode functions that are important for the intracellular events
described above.
s, since each mutant should
be defective in some step in infection.
infection, phagosome formation, and/or establishment determine its
intracellular fate.
![]()
MATERIALS AND METHODS
Top
Abstract
Introduction
Materials & Methods
Results
Discussion
References
80°C. Fetal calf serum (FCS) (catalog no. F-2442),
poly-D-lysine hydrobromide (200,000 MW) (catalog no.
P-1149), and all other reagents and chemicals and were purchased from
Sigma (St. Louis, Mo.). FCS was incubated at 56°C for 30 min to
inactivate the complement. Phosphate-buffered saline (PBS) was prepared
as 137 mM NaCl, 2.7 mM KCl, 4.3 mM Na2HPO4, and
1.4 mM KH2PO4 (pH 7.2). M63 salts contain 22.0 mM KH2PO4, 40.2 mM
K2HPO4, 14.6 mM
(NH4)2SO4, and 500 nM
FeSO4 (pH 6.5).
TABLE 1.
Strains of L. pneumophilaa
Bacterial viability assay. Propidium iodide (PI) is known to intercalate with DNA (23) in the nuclei of dead cells (28). Its exclusion by L. pneumophila was used as a rapid measurement of bacterial viability. A 40-µl suspension of L. pneumophila at approximately 109 bacteria per ml in M63 salts was added to 40 µl of a 100-µg/ml solution of PI in water. After a 15-min incubation at room temperature, 1.0 ml of M63 salts was added. The solution was centrifuged, the supernatant was removed, and the bacteria were resuspended in 1.0 ml of M63 salts. Bacteria were then visualized by epifluorescence and phase-contrast microscopy to determine the number of red fluorescent bacteria and the total number of bacteria, respectively (Fig. 1H, I, and J). The number of red fluorescent bacteria divided by the total number of bacteria was taken as a measure of cell death.
|
Preparation of FL-labeled L. pneumophila. Two- and 3-day-old cultures of L. pneumophila strains were scraped from ACES [N-(2-acetamido)-2-aminoethanesulfonic acid)-buffered charcoal-yeast extract (ABCYE) agar plates (11) and then suspended and washed three times in 100 mM potassium phosphate (pH 8.0). Right before use, solutions containing 50, 16.7, 5.6, and 1.9 mg of FSE per ml were made in dimethyl sulfoxide. The FSE solution (10 µl for each concentration) was added to approximately 1010 bacteria in 1.0 ml of 100 mM potassium phosphate (pH 8.0). The bacterium-FSE mixtures, in 1.6-ml plastic centrifuge tubes, were periodically inverted throughout a 20-min incubation at room temperature. After being labeled, the bacteria were washed five times in M63 salts and stored in the same solution overnight on ice.
Epifluorescence was used to determine which bacteria were suitably labeled. The fluorescein (FL) fluorescence of L. pneumophila from each of the labeling reactions was visually compared to that of other FL-labeled L. pneumophila that had previously gave an adequate intensity of FL fluorescence in the PLF assay described below. On the following day, the viability of the selected FL-labeled bacteria was determined on the basis of PI exclusion. Only those bacteria that were greater than 97% viable were suspended, at 108 per ml, in RPMI with 2 mM Gln and 10% NHS and used to infect monolayers of differentiated U937 cells.Properties of FL-labeled L. pneumophila. The derivatization of L. pneumophila with FI did not reduce its viability or cytopathogenicity. All of the FL-derivatized rod-shaped bacteria observed by phase-contrast microscopy emitted green fluorescence (data not shown) and formed colonies on ABCYE medium (1.08 ± 0.17 CFU per particle) to the same extent as non-FL-labeled L. pneumophila (0.94 ± 0.24 CFU per particle). The percentage of L. pneumophila that failed to exclude the dye PI after FL labeling (1.9% ± 1.3%) was not appreciably different than that before labeling (2.3% ± 1.4%), indicating that the labeling procedure affected neither the integrity of the bacterial membrane nor viability (Fig. 1H, I, and J). The FL labeling also did not alter the viability of any of the mutant L. pneumophila strains as judged by PI exclusion.
Labeling of L. pneumophila with FL did not alter its ability to carry out productive infections in M
-like cells.
Wild-type FL-labeled L. pneumophila JR32 killed
monolayers of differentiated HL-60 and U937 cells (data not shown) like
its non-FL-labeled counterpart as measured in a cytotoxicity assay
(30). Moreover, wild-type FL-labeled L. pneumophila JR32 multiplied in monolayers of differentiated U937
and HL-60 cells with the same growth kinetics and to the same extent as
nonlabeled bacteria (data not shown) as measured in a growth assay
(45). Finally, both FL-labeled and nonlabeled wild-type
L. pneumophila JR32 began to multiply at 10 h
postinfection (4 h after the last PLF time point was taken) as
determined by a synchronous infection growth assay (45). Thus, FL-labeled L. pneumophila is apparently able to
enter, survive in, and multiply in differentiated U937 cells like the
nonlabeled bacteria.
Preparation of FL-labeled Para-killed L. pneumophila.
FL-labeled L. pneumophila JR32 was
washed three times and suspended in 0.5 ml of 100 mM potassium
phosphate (pH 8.0). A 0.5-ml solution of 4% Para was mixed with the
bacteria, and the solution was incubated for 30 min at room
temperature. The reaction was quenched by adding 50 µl of 1 M
NH4Cl. The bacteria were then resuspended in PBS containing
50 mM NH4Cl and incubated at room temperature for an
additional 5 min. Finally, the bacteria were washed three times in M63
salts before being suspended at 108 per ml in RPMI with 2 mM Gln and 10% NHS. Para-treated JR32 (JR32-Para) was nonviable (less
than 10
9 CFU per bacterial particle) and permeable to PI
(data not shown).
Cell culture.
The human leukemia cell lines HL-60
(9) and U937 (41) were maintained in RPMI
supplemented with 2 mM Gln and 10% heat-inactivated FCS at 37°C
under 5% CO2-95% air. For L. pneumophila
cytotoxicity, growth, and synchronous growth assays, HL-60 and U937
cells were differentiated into M
-like cells by incubating them for 2 days with 10 ng of phorbol 12-myristate 13-acetate per ml in RPMI with 2 mM Gln and 10% NHS (15). Adherent cells were washed three times with RPMI containing 2 mM Gln and then incubated in RPMI with 2 mM Gln and 10% NHS prior to infection.
Preparation, infection, and fixation of U937 cells for confocal microscopy. For the PLF assay, monolayers of differentiated U937 cells were made by harvesting the cells at 1 × 106 per ml and resuspending the cells at 7.5 × 105 per ml in RPMI with 2 mM Gln, 10% NHS, 10 ng of phorbol 12-myristate 13-acetate per ml, and 1 mg of Rh-dextran per ml. The cell suspension (0.2 ml) was placed on a poly-D-lysine-coated glass coverslip (22 by 22 mm; no. 1, Gold Seal; Becton-Dickinson Labware) that had been first mounted on the bottom of a 35- by 10-mm culture dish (Corning 25000) with a 12-mm-diameter hole punched through the bottom. The coverslips were affixed to the plastic plates by using a mixture of paraffin and petroleum jelly at a 3-to-1 ratio. After a 40-h incubation under 5% CO2-95% air at 37°C, adherent cells were washed three times with RPMI containing 2 mM Gln at 37°C and then incubated in 100 µl of RPMI with 2 mM Gln and 10% NHS for 1 h under 5% CO2-95% air at 37°C.
The kinetics of PLF were measured after infecting U937 cells for 30 min. The differentiated U937 cells were infected by the addition of 100 µl of FL-labeled bacteria at 1.0 × 108 per ml in RPMI with 2 mM Gln and 10% NHS to produce a final concentration of 5 × 107 bacteria per ml. After a 0.5-h incubation under 5% CO2-95% air at 37°C, nonadherent bacteria were removed by washing the U937 monolayers three times with RPMI containing 2 mM Gln at 37°C. The infected U937 cells were then immobilized by adding 200 µl of RPMI with 2 mM Gln, 10% NHS, and 0.8% agarose at approximately 40°C over the monolayer. The overlay prevented the loss of infected U937 cells that tended to detach from glass coverslips after prolonged incubations and also limited the free diffusion of any remaining extracellular L. pneumophila as demonstrated in plaque assays (12, 30). For those infected U937 cells that were to have an additional incubation at 37°C under 5% CO2-95% air, approximately 0.5 ml of RPMI with 2 mM Gln and 10% NHS was placed on top of the agarose plug to prevent its desiccation. To fix the cells for microscopy, any medium in the culture dish was first aspirated. Approximately 3 ml of an ice-cold solution of PBS containing 4% Para was then added to the culture dish, and the cells were incubated for at least 12 h at 4°C. Finally, the Para-PBS solution was aspirated and replaced by 3 ml of PBS.Preparation of FL-labeled L. pneumophila for confocal microscopy. A 20-µl solution of FL-labeled L. pneumophila at 1010 per ml in RPMI with 2 mM Gln and 10% NHS was mixed with 200 µl of 2.0% agarose at approximately 40°C. The bacterial suspension was placed on coverslips previously mounted on the bottom of a culture dish with a hole punched out. Bacteria in the solidified agar were fixed and handled like the infected U937 cells described above.
Image acquisition. Fixed, infected U937 cells were examined by using a laser scanning confocal microscope (MRC 600; Bio-Rad Microscience, Cambridge, Mass.) on an inverted microscope (Axiovert; Zeiss, Oberkochen, Germany) with a 63× (numerical aperture, 1.4) Zeiss Plan-Apo infinity-corrected objective. Light from a 25-mW argon laser was passed through a discriminating filter (488 DF 10) to illuminate infected U937 cells. Emitted fluorescence was then passed through a dichroic reflector (DR 510 LP) and split into two beams by another dichroic reflector (DR 560 LP). One beam was passed through a discriminating filter (530 DF 30) and the other was passed through a long-pass filter (EF 575 LP) to simultaneously generate dual fluorescence images, I530 and I575, respectively. Images were recorded in fields where the FL fluorescence emanated from within U937 cells. This was verified by focusing up and down during image collection to ensure that the FL fluorescence was surrounded by punctate Rh fluorescence produced by the Rh-dextran that labeled the lysosomes. The average from eight scans was used to produce the final digitized images.
Determination of the distribution of L. pneumophila in infected U937 cells.
Monolayers of
differentiated U937 cells whose lysosomes were prelabeled with
Rh-dextran were infected with twofold increasing concentrations
(ranging from 4 × 106 to 1 × 109
bacteria per ml [final concentration]) of FL-labeled wild-type L. pneumophila JR32. After a 0.5-h incubation,
monolayers were washed three times with RPMI containing 2 mM Gln to
remove nonadherent bacteria, fixed with 4% Para in PBS, and then
examined by confocal microscopy. The observed number of internalized
L. pneumophila organisms per M
was determined by
adding the number of fluorescent FL-labeled L. pneumophila organisms among the punctate Rh fluorescence that
delineated the extent of the M
's cytoplasm. The expected number of
internalized bacteria per M
was calculated by multiplying the total
number of M
s examined by the Poisson probability distribution function P(n) = (mn/n!)(e
m),
where n equals the number of L. pneumophila
organisms internalized per M
and m equals the total
number of observed intracellular L. pneumophila
organisms divided by the total number of M
s examined. The
distribution of L. pneumophila within the M
s matched
a Poisson distribution as determined by chi-square analysis to measure
fit (P > 0.35 in one infection and P > 0.99 in the other eight infections). At the concentration of
FL-labeled L. pneumophila used in our PLF assay,
approximately 7% of the M
s are calculated to contain two or more
bacteria. Thus, in any given experiment, 10% or fewer of the M
s
with internalized FL-labeled L. pneumophila will be erroneously scored as fused when multiply infected M
s (7%) and degraded dead bacteria (maximally 3% as determined by PI exclusion) are taken into account.
Image analysis. Image processing was done with an image processor (Gould-Vicom IP8000; VICOM Visual Computing, Freemont, Calif.) run on a microVAX minicomputer (Digital Equipment Corporation, Maynard, Mass.). Digitized I530 and I575 had the background (B) subtracted to obtain background-corrected images, I530-B and I575-B, respectively, as described previously (32, 33). To resolve FI-labeled bacteria or any intracellular compartments containing FI, an automated procedure was used to remove dim pixels in the I530-B whose brightness was less than 40% of the brightest pixels found in the same spot (32). Spots defined in the I530-B were used to create a mask of the same areas in the I575-B. Pixels within these areas that have nonzero intensity values comprised the final spots used for analysis. The intensity values of the pixels within each trimmed spot of the I575-B were summed and divided by the sum of the corresponding pixel intensity values in the I530-B to obtain a ratiometric (R575/530) value for each spot. Spots were excluded from analysis if they were composed of fewer than 20 pixels, since the reliability of R575/530 values decreased rapidly as the size of the spot diminished below this number of pixels (data not shown). Detector saturation was avoided by excluding from analysis spots in either the I530 or the I575 that contained a pixel whose value was greater than 240 (of a maximum of 255).
Scoring of PLF.
PLF was scored for both intact and degraded
bacteria. For intact bacteria within M
s, the
R575/530 values of spots corresponding to
FL-labeled L. pneumophila were used to determine
whether PLF had occurred. Filter sets were chosen so that FI
fluorescence would register in both the I530 and
the I575. Thus, a mean ratiometric value of FL
fluorescence (RFI) and a standard deviation (SD)
could be calculated simply by obtaining R575/530
values of hundreds of FL-labeled L. pneumophila. The
RFL value depended on the acquisition settings
and was measured in each experiment. Since cellular autofluorescence was negligible, an increase in the R575/530
value of a spot that defined a bacterium was due to the presence of
coincident lysosomal Rh-dextran. Because the
R575/530 values assigned to FL-labeled L. pneumophila fit a normal distribution (see Fig. 2A),
a confidence value could be calculated based on the SD. Fusion was
scored when the R575/530 value exceeded the high
stringency value of four SDs above the RFL value
(
), thus ensuring that a negligible number (fewer than 0.01%) of
spots that corresponded to nonfused FL-labeled L. pneumophila will have, by statistical chance, an
R575/530 value that is higher. Studies with
unlabeled cells demonstrated that the increase in
R575/530 values associated with FL-labeled
L. pneumophila was due to its colocalization with
Rh-dextran, whose fluorescence is registered almost exclusively in the
pixels comprising the I575.
s. First, the number of infecting L. pneumophila
organisms within M
s was distributed in a Poisson fashion. The small
fraction of M
s infected (typically 10%) in a given PLF experiment
relates to a low probability (7%) of an infected M
containing two
or more L. pneumophila organisms. Thus, any M
s
containing more than one punctate vesicle of FL have a high (93%)
probability of arising from a single bacterium which had been degraded.
Second, the FL fluorescence from degraded bacteria was retained within
the M
and did not spread to surrounding cells (Fig. 1C and D) (see
below). Typically, many punctate vesicles were formed after FL-labeled L. pneumophila was degraded (Fig. 1C, D, and E) (see
below). M
s containing these FL-containing compartments were called
multivesiculated (Mv) M
s and appeared yellow [Fig. 1C(RG)] or
green [Fig. 1D(RG)], depending on how much Rh-dextran colocalized
with these compartments.
By using the method described above, PLF was scored for individual
bacteria that gained entry into U937 M
s. The fraction of
L. pneumophila that had fused with lysosomes at any
given time after infection was calculated as (fused L. pneumophila + Mv M
s)/(fused L. pneumophila + Mv M
s + nonfused L. pneumophila).
Statistical analysis. The probabilities and statistical significance for chi-square analysis, paired two-tailed Student's t test, SD, normal distribution, and Poisson distribution were calculated as described by Remington and Schork (36). Probability (P) values of less than 0.05 or 0.001 were judged significant or highly significant, respectively.
| |
RESULTS |
|---|
|
|
|---|
Parameters affecting colocalization of phagosomal and lysosomal
markers as an indicator of PLF.
To compare the abilities of
wild-type and mutant L. pneumophila strains to inhibit
PLF, a quantitative colocalization assay was developed that measures
the presence of a lysosomal marker within phagosomes containing
individual bacteria. For two reasons, confocal fluorescence microscopy
was used to determine colocalization. First, phagosomes and lysosomes
containing different fluorophores can be viewed within a thin focal
plane. Second, digitized images can be acquired and used for
quantification. To mark phagosomes, L. pneumophila was
covalently labeled with the fluorescent dye carboxy-FL. The FL-labeled
L. pneumophila bacteria were then internalized by
U937-derived M
s. The lysosomes of these M
s were preloaded with
Rh-dextran for 40 h prior to infection. The Rh-dextran is taken up
by fluid phase endocytosis and delivered to lysosomes (14).
PLF could then be scored by determining the fraction of phagosomes
containing FL-labeled L. pneumophila that had
colocalized with lysosomes bearing Rh-dextran. To make the scoring of
FL and Rh colocalization objective and to make its detection more
sensitive, fluorescence images were digitized and processed to quantify
each fluorophore. Thus, small amounts of Rh-dextran added incrementally to phagosomes containing FL-labeled L. pneumophila upon
transient fusions with lysosomes could be measured (10).
s, (iii) a low
multiplicity of infection was used to minimize multiple infections so
that M
s containing many discrete FL-containing compartments could be
scored as a single PLF event (such M
s arise when an FL-labeled
bacterium within a phagolysosome is degraded and fragments are
distributed throughout the cell [see below]), (iv) the infection was
performed for a discrete period of time (30 min) so that kinetics of
PLF could be monitored, and (v) measurements were made before the internalized bacteria multiplied, which would have interfered with
counting the initial number of bacteria that had been taken up by the
M
(see Materials and Methods for a detailed description of each
parameter).
Colocalization and dispersal of FL-labeled bacterial fragments as a
measure of PLF for intact and digested FL-labeled L. pneumophila.
To characterize the behavior of the FL-labeled
L. pneumophila and the Rh-labeled dextran within M
s,
we took advantage of the fluorescence emission of FL, which is greater
at 530 nm than at 575 nm. Images of fixed U937 cells, in which only a
few cells (approximately 10%) were infected (Fig. 1G shows for a
representative field), were acquired both at 530 nm
(I530), which is near the FL emission maximum,
and at 575 nm (I575), which is near the Rh emission maximum but which also contains some FL fluorescence. Thus,
FL-labeled L. pneumophila organisms that are observed
will occupy areas at identical pixel locations in each image.
Consequently, a ratiometric (R575/530) value can
be assigned to these areas or spots by simply dividing the total
fluorescence power of one spot identified in the processed
I575 by the total fluorescence power of the
corresponding spot found in the processed I530
(see "Image analysis" in Materials and Methods). In each
experiment, a standard mean ratiometric value for fluorescein
(RFL) was determined by averaging the
R575/530 values of many FL-labeled
L. pneumophila bacteria. A threshold value,
, which
equals the RFL value of FL plus four SDs,
was then calculated (Fig. 2A). The
value established the criterion used to score PLF. When there was no
colocalization (i.e., R575/530
), the
phagosomes containing L. pneumophila were scored as not
fused [Fig. 1A(RG) and G]. In contrast, when the two fluorescent
markers colocalized (i.e., R575/530 >
), phagosomes containing FL-labeled L. pneumophila were
scored as fused [Fig. 1B(RG) and F]. The stringent
value also
guaranteed that fewer than 0.01% of the spots will have, by
statistical chance, an R575/530 value that is
greater than
and be scored as a fusion event.
|
plasma membrane components with trace amounts of Rh-dextran, these possibilities seem unlikely. FL-labeled L. pneumophila that internalized in the presence of 1 mg of
extracellular Rh-dextran per ml formed phagosomes with associated
R575/530 values (0.538 ± 0.069) that were
almost identical to the RFL values (0.529 ± 0.064) corresponding to isolated FL-labeled L. pneumophila. These results indicate that very little extracellular
or plasma membrane-bound Rh-dextran is taken into the phagosome, and
this therefore cannot account for the increase in
R575/530 values seen in our colocalization experiments. We conclude that colocalization (i.e.,
R575/530 >
) is indicative of PLF (Fig. 2).
In the process of collecting images, we observed many instances of Mv
M
s that contained a large number of FL-containing compartments. We
infer that these represent the products of bacterial digestion following PLF [Fig. 1C(G), D(G), and E]. The Mv M
appearance ranged from yellow to green depending on the amount of Rh-dextran that
colocalized with these FL-containing compartments [Fig. 1C(RG) and
D(RG), respectively]. Infrequently, an Mv M
containing both green
and yellow compartments was seen 6 h after infection (Fig. 1E).
The Mv M
s probably represent the products of a single PLF event and
not multiple infection of an M
, for two reasons. First, these M
s
occur at frequencies much greater than the fraction of M
s expected
to be multiply infected (see Materials and Methods). Second, the number
of FL-containing compartments found within these M
s greatly exceeded
the number of FL-labeled L. pneumophila organisms found
in any M
that had been infected with even a 20-fold-greater concentration of bacteria (data not shown).
Mv M
s did not arise from the uptake of extracellular FL that may
have been released into the medium during the initial incubation with
FL-labeled L. pneumophila. No low basal level
of FL fluorescence was ever detected throughout the M
monolayers
[Fig. 1A(G), B(G), C(G), and D(G)]. FL fluorescence also remained
contained within M
s that had degraded the FL-labeled L. pneumophila, since the FL fluorescence was never seen to spread
into adjacent cells (Fig. 1C and D).
The Mv M
s observed at 6 h postinfection also were not
formed by the multiplication of FL-labeled L. pneumophila within the host cells. Replication of FL-labeled
wild-type L. pneumophila JR32 in synchronously
infected M
s was not detectable until 10 h postinfection, a full
two L. pneumophila intracellular generation times (2 h
per generation) beyond the 6-h time point at which PLF was measured
(data not shown). Thus, by objectively quantifying fusion in M
s
infected at a low multiplicity of bacteria, PLF could be measured on a
per-bacterium basis. The total Mv M
s plus intact internalized
bacteria that had associated R575/530 values greater than the
value represented the number of bacteria whose phagosomes fused with lysosomes. Histograms of PLF were then generated and used to calculate the fraction of individual FL-labeled
L. pneumophila organisms that had either fused to a
lysosome or fused and been degraded (Fig. 2B and C) (see Materials and
Methods).
Kinetics of PLF for wild-type, mutant, and killed L. pneumophila. In order to find out if measuring PLF by these criteria yielded results similar to those obtained by others with electron microscopy, we compared levels of PLF for three types of L. pneumophila as a function of time after infection: live wild-type strain JR32; live avirulent mutant 25D, which is known to be defective in preventing PLF; and Para-killed JR32 (17). Initial time course experiments indicated that measurements made 0.5 and 6 h after infection would suffice to differentiate the three samples (data not shown). The fractions of bacteria that fused at these times were calculated from histograms (Fig. 2), and the PLF assay was then repeated so that meaningful statistical comparisons could be made.
The fraction of phagosomes containing FL-labeled JR32 that fused with lysosomes 0.5 h after infection was 29%, significantly above the 10% background expected in the assay due to dead bacteria and multiple infections (Fig. 3) (see Materials and Methods). Approximately the same low level of fusion was also found when PLF was measured 5.5 h later (P = 0.28 by Students' t test). Thus, 29% of phagosomes containing live wild-type L. pneumophila fuse with lysosomes early after infection. However, once the phagosome containing JR32 is established, no additional fusion seems to occur (Fig. 3).
|
s
represented nearly all of the PLF events scored for 25D at 6 h
postinfection (data not shown). This not only supports the idea that
the maximal number of fused 25D phagosomes was reached at 6 h
after infection but also supports the idea that PLF precedes Mv M
s
formation. Thus, in contrast to phagosomes containing JR32, phagosomes
bearing 25D initially resist PLF but then lose this ability with time.
The levels of PLF were also measured for cells infected with FL-labeled
L. pneumophila killed with Para (JR32-Para). Unlike phagosomes containing living wild-type JR32 and mutant 25D, phagosomes containing JR32-Para rapidly fused with lysosomes during the first 0.5 h of incubation (Fig.
4A). The high fraction
(0.86 ± 0.04) of phagosomes containing JR32-Para that fused with
lysosomes 6 h after infection was not statistically different
(P = 0.31) from the fraction fused 0.5 h after
infection (0.67 ± 0.06), confirming the complete inability of
nonviable L. pneumophila to prevent PLF immediately
after infection (19).
|
s containing predominately green vesicles (Fig. 1D) that comprised the total fusion events of all
strains of L. pneumophila (except JR32) at 6 h
postinfection (data not shown). The high
value used as a stringent
criterion to measure fusion demands that a significant amount of
Rh-dextran be colocalized with the FL-labeled L. pneumophila. With 0.86 as an upper limit for the fraction
fused, essentially all of the phagosomes containing 25D seemed to have
been fused with lysosomes 6 h after infection, since the fraction
fused for 25D was not statistically different than that for JR32-Para
(P = 0.23). Thus, the results obtained with this assay
are in basic agreement with those obtained by using a completely
different experimental system (17). In addition, we have
obtained new information about the time dependence of fusion events
that occur between phagosomes containing either wild-type L. pneumophila or the mutant 25D in M
-like cells that are mainly
singly infected.
Phagosomes containing icm and dot mutants rapidly fuse with lysosomes. As described in the introduction, we have characterized a total of 20 genes (icm and dotA) whose products are required for both intracellular multiplication and host cell killing. In order to find out whether these genes play a role in determining the ability of L. pneumophila to prevent PLF, we measured the levels of PLF for eight different mutants carrying insertion mutations in six of these genes. Instead of the low levels of PLF displayed by JR32 and 25D early after infection, seven of the eight mutants analyzed were found in phagosomes that rapidly fused with host lysosomes. Indeed, for L. pneumophila LELA2955 (icmX), LELA4004 (icmX), LELA3118 (dotA), LELA1984 (icmE), LELA2474 (icmU), LELA3150 (icmB), and LELA3278 (icmR), the fraction of PLF after 0.5 h of infection was as high as that for JR32-Para, ranging from 0.64 to 0.76 (Fig. 4B, C, and E). The fraction of PLF for these mutants at 0.5 h postinfection was significantly higher than the PLF observed for either JR32 or 25D (P < 0.05).
Like for the nonviable JR32-Para, the fraction of fused phagosomes did not increase appreciably with an additional 5.5 h of incubation (P values ranged between 0.09 and 0.97), indicating that all of the phagosomes containing these mutants fused within 0.5 h after being internalized. Moreover, the average fractions of fused phagosomes for these mutants after infection (0.68 ± 0.04 at 0.5 h and 0.73 ± 0.04 at 6 h) are similar to those for JR32-Para (0.67 ± 0.06 at 0.5 h and 0.86 ± 0.04 at 6 h), indicating a complete lack of ability to prevent fusion with lysosomes. Early fusion with degradative lysosomal compartments is also suggested by the formation of Mv M
s (Fig. 4). More Mv M
s were found
0.5 h after infection with FL-labeled L. pneumophila LELA2955 (icmX), LELA4004
(icmX), LELA3118 (dotA), LELA1984
(icmE), LELA2474 (icmU), LELA3150
(icmB), and LELA3278 (icmR) than were found
0.5 h after infection with FL-labeled L. pneumophila 25D or JR32. With a 5.5-h longer incubation, the Mv
M
s comprised greater than 50% of the total fraction fused, a value
similar to that found for JR32-Para.
Although seven of the eight mutants tested have no ability to prevent
PLF within 0.5 h of infection, mutant LELA1802 (icmX) seems to maintain a marginal ability to prevent PLF (Fig. 4D). At
0.5 h after infection, Phagosomes containing FL-labeled LELA1802 (icmX) colocalized with lysosomes to a significantly higher
degree (P = 0.0011) than phagosomes containing
wild-type JR32, indicating that LELA1802 is defective in preventing
PLF. However, although phagosomes containing LELA1802 (icmX)
also colocalize with lysosomes more than phagosomes containing 25D
after 0.5 h of infection, the difference was not statistically
significant (P = 0.11), indicating that they may have a
partial ability to prevent PLF, like 25D. At 6 h after infection,
the fractions of phagosomes containing LELA1802 (icmX) and
25D that fused with lysosomes, 0.63 ± 0.04 and 0.68 ± 0.02, respectively, were statistically indistinguishable (P = 0.42) and similar in magnitude to that for JR32-Para (0.64 ± 0.04). Thus, LELA1802 (icmX) is also unable to inhibit PLF
within 6 h but may possess a slight ability to prevent PLF early
in infection.
These results indicate that strains with null mutations in six of the
genes all exhibit the same phenotype, a total lack of ability to
inhibit PLF. The fact that phagosomes containing these mutants are all
fused with lysosomes as rapidly as 30 min following infection indicates
that the decision about whether each phagosome will or will not fuse
with lysosomes is determined during the initial encounter between the
bacteria and the host cell. In addition, at least the six gene products
tested here (those of icmX, dotA, icmB, icmR, icmU, and icmE)
are essential for determining this key aspect of the intracellular fate
of L. pneumophila.
| |
DISCUSSION |
|---|
|
|
|---|
Infection of host cells by L. pneumophila results in the formation of a specialized compartment (LSP) that is essential for intracellular bacterial survival and growth. Lack of fusion between the LSP and lysosomes is of paramount importance for L. pneumophila, since mutants that are unable to prevent PLF are unable to multiply intracellularly, do not kill host cells, and do not cause disease in animals (18, 19, 29). The experiments reported in this paper distinguish three types of L. pneumophila-containing phagosomes based on their ability to fuse with lysosomes. The first type consists of those that do not measurably fuse with lysosomes. These are exemplified by the 67% of the phagosomes containing wild-type L. pneumophila JR32 that never colocalized with the Rh-dextran marking the lysosomal compartments, even 6 h after infection. The second type, which initially resist fusion but eventually do fuse with lysosomes between 0.5 and 6 h postinfection consists of those exemplified by mutants 25D and LELA1802 (icmX). The third type contains strains that have no capacity to prevent PLF; these phagosomes have completely fused to lysosomes at some point prior to 0.5 h postinfection. These are exemplified by the phagosomes containing either Para-killed wild-type JR32 or the remaining transposon-generated mutant L. pneumophila strains.
Our results demonstrate that the ability to prevent PLF during or right after phagocytosis seems to require at least the products of the icmX, icmE, icmR, icmB, icmU, and dotA genes of L. pneumophila (Table 1). Mutants containing transposon insertions in these genes are as defective as non-viable JR32-Para in preventing PLF within 30 min of bacterial uptake. Since de novo protein synthesis is not required to prevent PLF, expression of the dotA and icm genes must occur before the phagocytosis of L. pneumophila (22). In this regard, the 29% of viable FL-labeled wild-type L. pneumophila JR32 organisms whose phagosomes fail to resist PLF may not sufficiently express the putative dotA and icm gene products. Such population heterogeneity may explain why L. pneumophila grown in Acanthamoeba castellani is more invasive for epithelial cells (6), and why coinoculation of L. pneumophila and Hartmannella vermiformis increases growth of L. pneumophila within the lungs of mice (5). Both types of cocultivations may enrich for L. pneumophila populations that sufficiently express the information encoded by the dotA and icm loci. Consequently, all the L. pneumophila would be able to prevent PLF and thus display increased invasiveness and bacterial multiplication, both of which are linked to increased virulence.
Within 30 min of infection, all dotA and icm L. pneumophila mutants tested here were found mainly in phagolysosomes. PLF seems to be permanently inhibited only by wild-type L. pneumophila that makes and maintains a proper LSP. Once formed, the LSP may then have all the determinants necessary to specify its subsequent intracellular trafficking. Thus, our results are most consistent with a concerted model of gene expression and do not support a model in which different icm gene products act at different stages of the infection process. If this had been the case, some of the mutants might have retained the ability to prevent PLF and been defective at a later step. While we cannot rigorously exclude the possibility that we inadvertently chose only those mutants that were defective in preventing PLF and that other mutants would retain this ability, we feel that this is unlikely because the mutations represent different regions within the two different loci containing the icm and dotA genes. Our model predicts that null mutations in all of the icm genes should cause the same rapid, high-level PLF phenotype.
Evidence for sequential gene activation, however, has recently been obtained (43). Based on finding distinct intracellular fates of bacterial mutants defective for intracellular growth, Swanson and Isberg concluded that "corresponding gene products are likely to act in different bacterial pathways" (43). These differing conclusions may be due to a variety of experimental differences, including differences in the viability of the mutants, differences due to the microscopy techniques used, and, finally, differences in the nature of the mutants analyzed. The mutants studied by Swanson and Isberg are likely the result of missense mutations generated by ethyl methanesulfonate mutagenesis and may display complex phenotypes as a result of partial activities of the mutated gene products (43). Indeed, some of the mutants they studied are reminiscent of 25D and LELA1802, which exhibit a partial ability to prevent PLF. Since approximately 6 h is needed for lysosomes to completely fuse with phagosomes containing 25D, it may have time to display special intracellular trafficking properties like the mutants studied by Swanson and Isberg. In contrast, the mutants analyzed in our study all contained a single, well-defined transposon insertion. The transposon insertion is the only mutation in the mutants, since moving the mutation to a fresh genetic background produces the same phenotypes (37).
Only one of the mutants that contained a well-defined mutation
(transposon insertion) and was defective in killing M
s, LELA1802 (icmX), seems to temporarily resist PLF at 0.5 h
postinfection. Oddly, the transposon inserted in the icmX
gene of LELA1802 is located between the other two transposon insertions
found in LELA4004 and LELA2955. It seems that the truncated
icmX gene product made only in LELA1802 confers enough
activity to allow its phagosome to resist PLF. Nevertheless, this
activity cannot be very strong, since within 6 h after infection,
phagosomes containing LELA1802 fuse with host lysosomes. The phenotype
exhibited by LELA1802 suggests that the activity of one icm
gene (icmX) may be needed after phagosome
formation. Moreover, the fact that the mutants containing
icm and dotA disruptions are placed in phagosomes
that readily fuse with lysosomes does not exclude the possibility that these genes function at a later time in the infection. Obviously, further experimentation on the activity of the dotA and
icm genes during infection is needed.
Occasionally, Mv M
s containing both green and yellow compartments
were seen 6 h after infection (Fig. 1E). These Mv M
s may have arisen after FL-labeled L. pneumophila fused
with lysosomal compartments lacking Rh-dextran. The degraded
bacterial contents may then have been distributed through a lysosomal
network devoid of Rh-dextran. Alternatively, lower-molecular-weight
molecules of FL (and its derivatives), thought to be liberated by the
digestion of FL-labeled L. pneumophila in a
phagolysosome, may partition from high-molecular-weight molecules like
Rh-dextran (3, 44). The partitioning would form compartments
containing only FL fluorescence despite the presence of lysosomes
containing Rh-dextran.
Phagosomes bearing mutants LELA1984 (icmE), LELA3278
(icmR), LELA3150 (icmB), and LELA2474
(icmU), which displayed some ability to kill M
s (50%
lethal doses [LD50s] of less than 500,000 relative to
that for wild-type strain JR32), seem to fuse as readily to lysosomes
as phagosomes containing LELA1802 (icmX), LELA2955
(icmX), LELA3118 (dotA), and LELA4004
(icmX), whose M
killing ability is below the level of
detection (relative LD50s of greater than 500,000) (Table
1). This indicates that L. pneumophila may have a
killing mechanism which is independent of its ability to survive and
multiply within M
s. This killing ability, which seems to be present
only when large numbers of L. pneumophila organisms are
incubated with M
-like cells, may be due to a reported cytotoxin of
L. pneumophila (13, 24).
Previously, investigators used electron microscopy to measure PLF by scoring the frequency at which recognizable bacteria colocalized with the lysosomal marker acid phosphatase or electron-dense particles that were allowed to accumulate in lysosomes before infection (19, 40). There are limitations in both of these methods. Since the bacteria are subjectively identified, underestimates of PLF will occur when lysosomal degradation obscures their morphological features. Indeed, complete degradation would eliminate that population of bacteria whose phagosomes fused with lysosomes. Additionally, PLF studies usually employed host cells that were highly infected with bacteria, which may make counting the degraded bacteria difficult.
The pathogen L. pneumophila subverts many host defense
mechanisms in order to gain access to an environment conducive for its
survival and growth. The fact that this environment is a phagosome within human macrophages presents the additional challenge of avoiding
fusion to lysosomes, a trait shared by other intracellular pathogens
(1, 16, 27). Although the molecular basis for PLF inhibition
and regulation is unknown, bacterial entry seems to play an important
role in determining the fate of intracellular pathogens. For example,
Toxoplasma gondii and L. pneumophila, when
coated with antibodies and allowed to infect cells expressing the
M
-lymphocyte Fc receptor, will form phagosomes that fuse to
lysosomes (19, 26). The icm and dotA
genes of L. pneumophila therefore appear to control the
properties displayed by the LSP and act early during its formation
and/or its establishment.
| |
ACKNOWLEDGMENTS |
|---|
We are indebted to Mike Hillmeyer for assistance in computer programming and maintenance. For helpful discussion, we thank John Presley, Moira Lawson, Nadia Khelef, Cynthia Panagiotidis, and David Figurski. For unpublished sequence information, we thank Mary Purcell and Laura Hales. We also thank Carmen Rodriguez for technical assistance.
This work was supported by National Research Service Award AI-08299 (to L.A.W.) and National Institutes of Health grants AI-2354 (to H.A.S.) and DK27083 (to F.R.M.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Microbiology, College of Physicians and Surgeons, Columbia University, 701 West 168th St., New York, NY 10032. Phone: (212) 305-6913. Fax: (212) 305-1468. E-mail: shuman{at}cuccfa.ccc.columbia.edu.
Present address: Department of Medicine, Nephrology Section,
Indiana University Medical Center, Indianapolis, IN 46202.
Present address: Department of Biochemistry, Cornell University
Medical College, New York, NY 10021.
Editor: J. T. Barbieri
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Armstrong, J. A., and P. D. Hart.
1975.
Phagosome-lysosome interactions in cultured macrophages infected with virulent tubercle bacilli.
J. Exp. Med.
142:1-16 |
| 2. | Berger, K. H., and R. R. Isberg. 1993. Two distinct defects in intracellular growth complemented by a single genetic locus in Legionella pneumophila. Mol. Microbiol. 7:7-19[Medline]. |
| 3. |
Berthiaume, E. P.,
C. Medina, and J. A. Swanson.
1995.
Molecular size-fractionation during endocytosis in macrophages.
J. Cell Biol.
129:989-998 |
| 4. | Brand, B. C., A. B. Sadosky, and H. A. Shuman. 1994. The Legionella pneumophila icm locus: a set of genes required for intracellular multiplication in human macrophages. Mol. Microbiol. 14:797-808[Medline]. |
| 5. | Brieland, J., M. McClain, L. Heath, C. Chrisp, G. Huffnagle, M. LeGendre, M. Hurley, J. Fantone, and C. Engleberg. 1996. Coinoculation with Hartmannella vermiformis enhances replicative Legionella pneumophila lung infection in a murine model of Legionnaires' disease. Infect. Immun. 64:2449-2456[Abstract]. |
| 6. |
Cirillo, J. D.,
S. Falkow, and L. S. Tompkins.
1994.
Growth of Legionella pneumophila in Acanthamoeba castellanii enhances invasion.
Infect. Immun.
62:3254-3261 |
| 7. |
Clemens, D. L., and M. A. Horwitz.
1993.
Hypoexpression of major histocompatibility complex molecules on Legionella pneumophila phagosomes and phagolysosomes.
Infect. Immun.
61:2803-2812 |
| 8. |
Clemens, D. L., and M. A. Horwitz.
1992.
Membrane sorting during phagocytosis: selective exclusion of major histocompatibility complex molecules but not complement receptor CR3 during conventional and coiling phagocytosis.
J. Exp. Med.
175:1317-1326 |
| 9. |
Collins, S. J.,
F. W. Ruscetti,
R. E. Gallagher, and R. C. Gallo.
1978.
Terminal differentiation of human promyelocytic leukemia cells induced by dimethyl sulfoxide and other polar compounds.
Proc. Natl. Acad. Sci. USA
75:2458-2462 |
| 10. |
Desjardins, M.,
L. A. Huber,
R. G. Parton, and G. Griffiths.
1994.
Biogenesis of phagolysosomes proceeds through a sequential series of interactions with the endocytic apparatus.
J. Cell Biol.
124:677-688 |
| 11. |
Feeley, J. C.,
G. W. Gorman,
R. E. Weaver,
D. C. Mackel, and H. W. Smith.
1978.
Primary isolation media for Legionnaires' disease bacterium.
J. Clin. Microbiol.
8:320-325 |
| 12. |
Fernandez, R. C.,
S. H. Lee,
D. Haldane,
R. Sumarah, and K. R. Rozee.
1989.
Plaque assay for virulent Legionella pneumophila.
J. Clin. Microbiol.
27:1961-1964 |
| 13. |
Friedman, R. L.,
B. H. Iglewski, and R. D. Miller.
1980.
Identification of a cytotoxin produced by Legionella pneumophila.
Infect. Immun.
29:271-274 |
| 14. | Geisow, M. J. 1984. Fluorescein conjugates as indicators of subcellular pH. Exp. Cell Res. 150:29-35[Medline]. |
| 15. | Hass, R., H. Bartels, N. Topley, M. Hadman, L. Kohler, M. Goppelt-Strube, and K. Resch. 1989. TPA-induced differentiation and adhesion of U937 cells: changes in ultrastructure, cytoskeletal organization and expression of cell surface antigens. Eur. J. Cell Biol. 48:282-293[Medline]. |
| 16. | Heinzen, R. A., M. A. Scidmore, D. D. Rockey, and T. Hackstadt. 1996. Differential interactions with endocytic and exocytic pathways distinguish parasitophorous vacuoles of Coxiella burnetii and Chlamydia trachomatis. Infect. Immun. 64:796-809[Abstract]. |
| 17. |
Horwitz, M. A.
1987.
Characterization of avirulent mutant Legionella pneumophila that survive but do not multiply within human monocytes.
J. Exp. Med.
166:1310-1328 |
| 18. |
Horwitz, M. A.
1983.
Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.
J. Exp. Med.
158:1319-1331 |
| 19. |
Horwitz, M. A.
1983.
The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.
J. Exp. Med.
158:2108-2126 |
| 20. | Horwitz, M. A. 1984. Phagocytosis of the Legionnaires' disease bacterium (Legionella pneumophila) occurs by a novel mechanism: engulfment within a pseudopod coil. Cell. 36:27-33[Medline]. |
| 21. |
Horwitz, M. A., and F. R. Maxfield.
1984.
Legionella pneumophila inhibits acidification of its phagosome in human monocytes.
J. Cell Biol.
99:1936-1943 |
| 22. | Horwitz, M. A., and S. C. Silverstein. 1983. Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin. J. Clin. Invest. 71:15-26. |
| 23. |
Hudson, B.,
W. B. Upholt,
J. Devinny, and J. Vinograd.
1969.
The use of an ethidium analogue in the dye-buoyant density procedure for the isolation of closed circular DNA: the variation of the superhelix density of mitochondrial DNA.
Proc. Natl. Acad. Sci. USA
62:813-820 |
| 24. |
Husmann, L. K., and W. Johnson.
1994.
Cytotoxicity of extracellular Legionella pneumophila.
Infect. Immun.
62:2111-2114 |
| 25. | Isberg, R. R. 1994. Intracellular trafficking of Legionella pneumophila within phagocytic cells, p. 263-278. In V. L. Miller, J. B. Kaper, D. A. Portnoy, and R. R. Isberg (ed.), Molecular genetics of bacterial pathogenesis. American Society for Microbiology, Washington, D.C. |
| 26. |
Joiner, K. A.,
S. A. Fuhrman,
H. M. Miettinen,
L. H. Kasper, and I. Mellman.
1990.
Toxoplasma gondii: fusion competence of parasitophorous vacuoles in Fc receptor-transfected fibroblasts.
Science
249:641-646 |
| 27. | Jones, T. C., and J. G. Hirsch. 1972. The interaction between Toxoplasm gondii and mammalian cells. II. The absence of lysosomal fusion with phagocytic vacuoles containing living parasites. J. Exp. Med. 136:1173-1194[Abstract]. |
| 28. |
Krishan, A.
1975.
Rapid flow cytofluorometric analysis of mammalian cell cycle by propidium iodide staining.
J. Cell Biol.
66:188-193 |
| 29. |
Marra, A.,
S. J. Blander,
M. A. Horwitz, and H. A. Shuman.
1992.
Identification of a Legionella pneumophila locus required for intracellular multiplication in human macrophages.
Proc. Natl. Acad. Sci. USA
89:9607-9611 |
| 30. | Marra, A., M. A. Horwitz, and H. A. Shuman. 1990. The HL-60 model for the interaction of human macrophages with the Legionnaires' disease bacterium. J. Immunol. 144:2738-2744[Abstract]. |
| 31. | Marra, A., and H. A. Shuman. 1992. Genetics of Legionella pneumophila virulence. Annu. Rev. Genet. 26:51-69[Medline]. |
| 32. | Maxfield, F. R. 1989. Measurement of vacuolar pH and cytoplasmic calcium in living cells using fluorescence microscopy. Methods Enzymol. 173:745-771[Medline]. |
| 33. | Maxfield, F. R., and K. W. Dunn. 1989. Studies of endocytosis using image intensification fluorescence microscopy and digital image analysis, p. 387-417. In B. Herman, and K. Jacobson (ed.), Digitized video microscopy. Alan R. Liss, Inc., New York, N.Y. |
| 34. |
Purcell, M., and H. Shuman.
1998.
The Legionella pneumophila icmGCDJBF genes are required for killing of human macrophages.
Infect. Immun.
66:2245-2255 |
| 35. | Rechnitzer, C., and J. Blom. 1989. Engulfment of the Philadelphia strain of Legionella pneumophila within pseudopod coils in human phagocytes. Comparison with other Legionella strains and species. APMIS 97:105-114[Medline]. |
| 36. | Remington, R. D., and A. Schork. 1985. Statistics with applications to the biological and health sciences. Prentice-Hall, Inc., Englewood Cliffs, N.J. |
| 37. |
Sadosky, A. B.,
L. A. Wiater, and H. A. Shuman.
1993.
Identification of Legionella pneumophila genes required for growth within and killing of human macrophages.
Infect. Immun.
61:5361-5373 |
| 38. | Segal, G., and H. A. Shuman. 1997. Characterization of a new region required for macrophage killing by Legionella pneumophila. Infect. Immun. 65:5057-5066[Abstract]. |
| 39. | Shuman, H. A., and M. A. Horwitz. 1996. Legionella pneumophila invasion of mononuclear phagocytes. Curr. Top. Microbiol. Immunol. 209:99-112[Medline]. |
| 40. | Steinberg, T. H., and J. A. Swanson. 1994. Measurement of phagosome-lysosome fusion and phagosomal pH. Methods Enzymol. 236:147-160[Medline]. |